Anny Shai
Associate Director
Neurological Surgery
School of Medicine

anny.shai@ucsf.edu

Publications (51)

Top publication keywords:
CocarcinogenesisGlioblastomaOncogene Proteins, ViralProto-Oncogene Proteins B-rafIsocitrate DehydrogenaseCancer VaccinesUterine Cervical NeoplasmsBrain NeoplasmsOligodendrogliomaOncogenesGliomaRepressor ProteinsTumor Suppressor Protein p53AstrocytomaMammary Neoplasms, Animal

Show all (46 more) Hide

  • A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas.
    Neuro-oncology 2024 Saijo A, Ogino H, Butowski NA, Tedesco MR, Gibson D, Watchmaker PB, Okada K, Wang AS, Shai A, Salazar AM, Molinaro AM, Rabbitt JE, Shahin M, Perry A, Clarke JL, Taylor JW, Daras M, Oberheim Bush NA, …
  • Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective.
    Cell 2024 Mathur R, Wang Q, Schupp PG, Nikolic A, Hilz S, Hong C, Grishanina NR, Kwok D, Stevers NO, Jin Q, Youngblood MW, Stasiak LA, Hou Y, Wang J, Yamaguchi TN, Lafontaine M, Shai A, Smirnov IV, Solomon DA, …
  • "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
    Acta neuropathologica 2023 Hadad S, Gupta R, Oberheim Bush NA, Taylor JW, Villanueva-Meyer JE, Young JS, Wu J, Ravindranathan A, Zhang Y, Warrier G, McCoy L, Shai A, Pekmezci M, Perry A, Bollen AW, Phillips JJ, Braunstein SE, …
  • EPCO-19. TUMOR-WIDE NEOANTIGEN-SPECIFIC T-CELLS INFILTRATING MUTANT IDH1 LOW-GRADE GLIOMAS AND PERSISTING IN PERIPHERAL BLOOD ALLOW FOR PERSONALIZED TCR-BASED IMMUNOTHERAPIES.
    Neuro-Oncology 2023 Darwin Kwok, Michael Zhang, Cliff Wang, Nicholas Stevers, Tyler Borrman, Zheng Pan, Benjamin Yuen, Songming Peng, Diana Nguyen, Michael Martin, Chibo Hong, Stephanie Hilz, Joanna Phillips, Anny Shai, …
  • NIMG-12. SPATIALLY MAPPING TREATMENT-EFFECT IN RECURRENT GLIOMA WITH PHYSIOLOGIC MRI AND DEEP LEARNING.
    Neuro-Oncology 2023 Jacob Ellison, Nate Tran, Rany Hanna, Joanna Phillips, Anny Shai, Devika Nair, Annette Molinaro, Valentina Pedoia, Yan Li, Tracy Luks, Javier Villanueva-Meyer, Mitchel Berger, Shawn Hervey-Jumper, …
  • NIMG-22. COMPARISON OF NON-INVASIVE, ML-GENERATED WHOLE-BRAIN SPATIAL RADIOPATHOMIC MAPS DERIVED FROM ANATOMICAL AND DIFFUSION-WEIGHTED MRI ON PATIENTS WITH NEWLY DIAGNOSED-GLIOMA.
    Neuro-Oncology 2023 Oluwaseun Adegbite, Nate Tran, Annette Molinaro, Joanna Phillips, Peter LaViolette, Samuel Bobholz, Jacob Ellison, Yan Li, Tracy Luks, Anny Shai, Devika Nair, Javier Villanueva-Meyer, Jennifer …
  • NIMG-64. IN VIVO METABOLIC PROFILING FOR RECURRENT GLIOMA.
    Neuro-Oncology 2023 Yan Li, Marisa Lafontaine, Adam Autry, Fei Jiang, Anny Shai, Joanna Phillips, Susan Chang
  • PATH-08. LONGITUDINAL MOLECULAR EVOLUTION OF IDH-WILDTYPE GLIOBLASTOMA IN ADULTS.
    Neuro-Oncology 2023 Calixto-Hope Lucas, Nadeem Al-Adli, Jacob Young, Ramin Morshed, Rohit Gupta, Jasper Wu, Ajay Ravindranathan, Julieann Lee, Anny Shai, Nancy Ann Oberheim Bush, Jennie Taylor, John de Groot, Nicholas …
  • Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma.
    bioRxiv : the preprint server for biology 2023 Nejo T, Wang L, Leung KK, Wang A, Lakshmanachetty S, Gallus M, Kwok DW, Hong C, Chen LH, Carrera DA, Zhang MY, Stevers NO, Maldonado GC, Yamamichi A, Watchmaker P, Naik A, Shai A, Phillips JJ, Chang …
  • Abstract 895: Tumor-wide neoantigen-specific T-cells infiltrating mutant IDH1 low-grade gliomas and persisting in peripheral blood allow for personalized TCR-based immunotherapies.
    Cancer Research 2023 Darwin W. Kwok, Michael Y. Zhang, Cliff Wang, Nicholas Stevers, Tyler Borrman, Zheng Pan, Benjamin Yuen, Songming Peng, Diana Nguyen, Michael Martin, Chibo Hong, Stephanie Hilz, Joanna Phillips, Anny …
  • Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 Hervey-Jumper SL, Zhang Y, Phillips JJ, Morshed RA, Young JS, McCoy L, Lafontaine M, Luks T, Ammanuel S, Kakaizada S, Egladyous A, Gogos A, Villanueva-Meyer J, Shai A, Warrier G, Rice T, Crane J, …
  • NIMG-46. TOWARDS PREDICTING TUMOR AGGRESSIVENESS WITH RADIOPATHOMIC ANALYSIS OF MULTI-PARAMETRIC ANATOMICAL, DIFFUSION-WEIGHTED, AND METABOLIC MRI IN PATIENTS WITH NEWLY-DIAGNOSED GLIOMAS.
    Neuro-Oncology 2022 Oluwaseun Adegbite, Nate Tran, Annette Molinaro, Joanna J Phillips, Jacob Ellison, Yan Li, Tracy Luks, Anny Shai, Devika Nair, Valentina Pedoia, Javier Villanueva-Meyer, Mitchel S Berger, Shawn L …
  • NIMG-61. IMPROVED GENERALIZABILITY OF RADIOPATHOMIC PROBABILISTIC MAPPING OF TREATMENT-INDUCED EFFECTS WITH PHYSIOLOGIC MR IMAGING AND DEEP LEARNING IN PATIENTS WITH RECURRENT GLIOBLASTOMA.
    Neuro-Oncology 2022 Jacob Ellison, Nate Tran, Annette Molinaro, Valentina Pedoia, Joanna J Phillips, Anny Shai, Devika Nair, Marisa Lafontaine, Angela Jakary, Tracy Luks, Javier Villanueva-Meyer, Susan M Chang, Mitchel S…
  • NIMG-65. IMPROVED SPATIAL MAPPING OF TUMOR AGGRESSIVENESS WITH 1H MAGNETIC RESONANCE SPECTROSCOPY AND DEEP LEARNING IN PATIENTS WITH NEWLY-DIAGNOSED GLIOMA.
    Neuro-Oncology 2022 Nate Tran, Yan Li, Jacob Ellison, Oluwaseun Adegbite, Joanna J Phillips, Annette Molinaro, Valentina Pedoia, Anny Shai, Devika Nair, Angela Jakary, Marisa Lafontaine, Javier Villanueva-Meyer, Mitchel …
  • PATH-07. MULTIPLATFORM MOLECULAR ANALYSES REFINE CLASSIFICATION AND PROGNOSTICATION OF GLIOMAS ARISING IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 1.
    Neuro-Oncology 2022 Calixto-Hope Lucas, Emily Sloan, Jangham Jung, Rohit Gupta, Jasper Wu, Harish Vasudevan, Anny Shai, Nicholas Whipple, Carol Bruggers, David Samuel, Ossama Maher, Rufei Lu, Kanish Mirchia, Daniel …
  • PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications.
    Neuro-oncology 2022 Mohamed E, Kumar A, Zhang Y, Wang AS, Chen K, Lim Y, Shai A, Taylor JW, Clarke J, Hilz S, Berger MS, Solomon DA, Costello JF, Molinaro AM, Phillips JJ
  • Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.
    Acta neuropathologica 2022 Lucas CG, Sloan EA, Gupta R, Wu J, Pratt D, Vasudevan HN, Ravindranathan A, Barreto J, Williams EA, Shai A, Whipple NS, Bruggers CS, Maher O, Nabors B, Rodriguez M, Samuel D, Brown M, Carmichael J, Lu…
  • CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma.
    Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Kumar A, Mohamed E, Tong S, Chen K, Mukherjee J, Lim Y, Wong CM, Boosalis Z, Shai A, Pieper RO, Gupta N, Perry A, Bollen AW, Molinaro AM, Solomon DA, Shieh JTC, Phillips JJ
  • Abstract 3797: 3D whole tumor analysis of the TERT promoter mutation in gliomas.
    Cancer Research 2022 Christina Leann Appin, Abigail K. Suwala, Stephanie Hilz, Radhika Mathur, Ivan V. Smirnov, Chibo Hong, Nicholas O. Stevers, Anny Shai, Albert Wang, Mitchel S. Berger, Susan M. Chang, Joanna J. …
  • Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging.
    Neuro-oncology 2022 Cluceru J, Interian Y, Phillips JJ, Molinaro AM, Luks TL, Alcaide-Leon P, Olson MP, Nair D, LaFontaine M, Shai A, Chunduru P, Pedoia V, Villanueva-Meyer JE, Chang SM, Lupo JM
  • Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas.
    The Journal of clinical investigation 2022 Ogino H, Taylor JW, Nejo T, Gibson D, Watchmaker PB, Okada K, Saijo A, Tedesco MR, Shai A, Wong CM, Rabbitt JE, Olin MR, Moertel CL, Nishioka Y, Salazar AM, Molinaro AM, Phillips JJ, Butowski NA, …
  • CTIM-24. RANDOMIZED TRIAL OF NEOADJUVANT VACCINATION WITH TUMOR-CELL LYSATE INDUCES T CELL RESPONSE IN LOW-GRADE GLIOMAS.
    Neuro-Oncology 2021 Jennie Taylor, Hirokazu Ogino, Takahide Nejo, David Gibson, Payal Watchmaker, Kaori Okada, Atsuro Saijo, Meghan Tedesco, Anny Shai, Cynthia Wong, Jane Rabbitt, Michael Olin, Christopher Moertel, …
  • IMMU-33. NEOANTIGEN-SPECIFIC T CELLS CAN INFILTRATE IDH-MUTANT LOWER GRADE GLIOMAS AND PERSIST IN THE PERIPHERAL BLOOD.
    Neuro-Oncology 2021 Michael Zhang, Cliff Wang, Zheng Pan, Benjamin Yuen, Songming Peng, Darwin Kwok, Takahide Nejo, Michael Martin, Chibo Hong, Stephanie Hilz, Joanna Phillips, Anny Shai, Nancy Ann Oberheim-Bush, Shawn …
  • NIMG-25. IMPROVING THE NONINVASIVE CLASSIFICATION OF GLIOMA GENETIC SUBTYPE WITH DEEP LEARNING AND DIFFUSION-WEIGHTED IMAGING.
    Neuro-Oncology 2021 Julia Cluceru, Joanna Phillips, Annette Molinaro, Yannet Interian, Tracy Luks, Paula Alcaide-Leon, Devika Nair, Marisa LaFontaine, Anny Shai, Pranathi Chunduru, Valentina Pedoia, Javier Villanueva-…
  • PATH-28. RE-DEFINING CLONALITY OF THE TERT PROMOTER MUTATION WITH DEEP SEQUENCING AND MAXIMAL SAMPLING OF NEWLY DIAGNOSED AND RECURRENT GBM AND OLIGODENDROGLIOMA.
    Neuro-Oncology 2021 Christina Appin, Abigail K Suwala, Stephanie Hilz, Radhika Mathur, Ivan Smirnov, Chibo Hong, Nicholas Stevers, Anny Shai, Mitchel Berger, Susan Chang, Joanna Phillips, Joseph Costello
  • Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas.
    Neuro-oncology 2021 Yu Y, Villanueva-Meyer J, Grimmer MR, Hilz S, Solomon DA, Choi S, Wahl M, Mazor T, Hong C, Shai A, Phillips JJ, Wainer BH, McDermott M, Haas-Kogan D, Taylor JW, Butowski N, Clarke JL, Berger MS, …
  • BIOM-38. PI3K/AKT/mTOR SIGNALING PATHWAY ACTIVITY IN IDH-MUTANT DIFFUSE GLIOMA.
    Neuro-Oncology 2020 Esraa Mohamed, Anupam Kumar, Stephanie Hilz, Albert Wang, Anny Shai, Jennie Taylor, Jennifer Clarke, Annette Molinaro, Julieann Lee, Joseph Costello, David Solomon, Joanna Phillips
  • PATH-12. TEMOZOLOMIDE-INDUCED HYPERMUTATION IS ASSOCIATED WITH HIGH-GRADE TRANSFORMATION, DISTANT RECURRENCE AND REDUCED SURVIVAL IN INITIALLY LOW GRADE IDH-MUTANT GLIOMAS.
    Neuro-Oncology 2020 Yao Yu, Javier Villanueva-Meyer, Susan Chang, Matthew Grimmer, Stephanie Hilz, David Solomon, Serah Choi, Michael Wahl, Tali Mazor, Chibo Hong, Anny Shai, Joanna Phillips, Michael McDermott, Daphne …
  • SURG-15. A NOVEL RISK MODEL TO DEFINE THE RELATIVE BENEFIT OF MAXIMAL EXTENT OF RESECTION WITHIN PROGNOSTIC GROUPS IN NEWLY DIAGNOSED DIFFUSE LOW-GRADE GLIOMA.
    Neuro-Oncology 2020 Shawn Hervey-Jumper, Annette Molinaro, Joanna Phillips, Ramin Morshed, Jacob Young, Yalan Zhang, Marisa LaFontaine, Tracy Luks, Simon Ammanuel, Sofia Kakaizada, Javier Villanueva-Meyer, Anny Shai, …
  • SURG-18. THE IMPACT OF NEUROLOGIC IMPAIRMENTS ON THE RELATIVE BENEFIT OF MAXIMAL EXTENT OF RESECTION IN NEWLY DIAGNOSED IDH-WILD TYPE GLIOBLASTOMA.
    Neuro-Oncology 2020 Shawn Hervey-Jumper, Annette Molinaro, Cecilia Dalle Ore, Desmond Brown, Yalan Zhang, Ramin Morshed, Marisa LaFontaine, Simon Ammanuel, Anny Shai, Gayathri Warrier, Terri Rice, Yi Lin, Jason Crane, …
  • Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomas.
    Neuro-oncology 2020 Cluceru J, Nelson SJ, Wen Q, Phillips JJ, Shai A, Molinaro AM, Alcaide-Leon P, Olson MP, Nair D, LaFontaine M, Chunduru P, Villanueva-Meyer JE, Cha S, Chang SM, Berger MS, Lupo JM
  • Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence, and reduced survival after transformation in initially low-grade IDH -mutant diffuse gliomas.
    Journal of Clinical Oncology 2020 Nancy Ann Oberheim Bush, Yao Yu, Javier Villanueva-Meyer, Matthew Grimmer, Stephanie Hilz, David Solomon, Serah Choi, Tali Mazor, Chibo Hong, Anny Shai, Joanna J. Phillips, Mike McDermott, Daphne A. …
  • Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.
    JAMA oncology 2020 Molinaro AM, Hervey-Jumper S, Morshed RA, Young J, Han SJ, Chunduru P, Zhang Y, Phillips JJ, Shai A, Lafontaine M, Crane J, Chandra A, Flanigan P, Jahangiri A, Cioffi G, Ostrom Q, Anderson JE, Badve C…
  • GENE-47. A 3D ATLAS TO EVALUATE THE SPATIAL PATTERNING OF GENETIC ALTERATIONS AND TUMOR CELL STATES IN GLIOMA.
    Neuro-Oncology 2019 Stephanie Hilz, Chibo Hong, Llewellyn Jalbert, Tali Mazor, Michael Martin, Anupam Kumar, Samuel Shelton, Karen Wong, Josie Hayes, Yao Yu, Michael Zhang, Tracy Luks, Marram Olson, Marisa Lafontaine, …
  • IMMU-11. SPATIOTEMPORAL IMMUNOGENOMIC ANALYSIS OF THE T-CELL REPERTOIRE IN IDH-MUTANT LOWER GRADE GLIOMAS.
    Neuro-Oncology 2019 Michael Zhang, Stephanie Hilz, Michael Martin, Chibo Hong, Yao Yu, Saumya Bollam, Matthew Grimmer, Timothy Looney, Geoffrey Lowman, Gauri Ganpule, Joanna Phillips, Anny Shai, Susan Chang, Jennifer …
  • Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma.
    Acta neuropathologica 2019 Lee JC, Mazor T, Lao R, Wan E, Diallo AB, Hill NS, Thangaraj N, Wendelsdorf K, Samuel D, Kline CN, Banerjee A, Auguste K, Raffel C, Gupta N, Berger M, Raleigh DR, Shai A, Phillips JJ, Bollen AW, Tihan…
  • PATH-29. CLINICAL SIGNIFICANCE OF TEMOZOLOMIDE-INDUCED SOMATIC HYPERMUTATION IN INITIALLY LOW-GRADE IDH-MUTANT DIFFUSE GLIOMAS.
    Neuro-Oncology 2018 Yao Yu, Stephanie Hilz, Matthew Grimmer, David Solomon, Serah Choi, Michael Wahl, Tali Mazor, Chibo Hong, Anny Shai, Joanna J Phillips, Javier Villanueva-Meyer, Michael McDermott, Daphne Haas-Kogan, …
  • SURG-02. A NOVEL RISK MODEL TO DEFINE THE RELATIVE BENEFIT OF MAXIMAL EXTENT OF RESECTION WITHIN PROGNOSTIC GROUPS IN NEWLY DIAGNOSED GLIOBLASTOMA.
    Neuro-Oncology 2018 Annette Molinaro, Shawn Hervey-Jumper, Seunggu J. Han, Ramin Morshed, Marisa Lafontaine, Nicole Ebrahimi, Jacob Young, Joanna J Phillips, Anny Shai, Gayathri Warrier, Terri Rice, Yi Lin, Jason Crane, …
  • NIMG-43. APPLICATION OF AN ADVANCED DIFFUSION-WEIGHTED MRI TECHNIQUE TO CHARACTERIZE GLIOMA MICROSTRUCTURE AND RELATIONSHIP TO HISTOPATHOLOGY.
    Neuro-Oncology 2016 Prasanna Parvathaneni, Joanna Phillips, Juan R Cabrera, Anny Shai, Soonmee Cha, Susan Chang, Sarah Nelson, Janine Lupo
  • TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis.
    Cancer research 2015 Shai A, Dankort D, Juan J, Green S, McMahon M
  • E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice.
    Cancer research 2010 Shai A, Pitot HC, Lambert PF
  • A role for HPV16 E5 in cervical carcinogenesis.
    Cancer research 2010 Maufort JP, Shai A, Pitot HC, Lambert PF
  • MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.
    Genes & development 2009 Olson P, Lu J, Zhang H, Shai A, Chun MG, Wang Y, Libutti SK, Nakakura EK, Golub TR, Hanahan D
  • Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer.
    Cancer research 2008 Chung SH, Wiedmeyer K, Shai A, Korach KS, Lambert PF
  • p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers.
    Cancer research 2008 Shai A, Pitot HC, Lambert PF
  • The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities.
    Cancer research 2007 Shai A, Brake T, Somoza C, Lambert PF